New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk

New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) was previously known as nonalcoholic fatty liver disease (NAFLD). The main characteristic of the disease is the process of long-term liver inflammation, which leads to hepatocyte damage followed by liver fibrosis and eventually cirrhos...

Full description

Bibliographic Details
Main Authors: Marija Branković, Marija Dukić, Tijana Gmizić, Višeslav Popadić, Novica Nikolić, Ana Sekulić, Milica Brajković, Jelena Đokić, Edvin Mahmutović, Ratko Lasica, Marko Vojnović, Tamara Milovanović
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Diagnostics
Subjects:
MASLD
cardiovascular diseases
metabolic syndrome
pharmacotherapy
Online Access:https://www.mdpi.com/2075-4418/14/2/229

Internet

https://www.mdpi.com/2075-4418/14/2/229

Similar Items